Author

Andrew David Brim

Observed name: Andrew D. Brim

Institutions: Medical University of South Carolina, University of Florida, MUSC Hollings Cancer Center

Observed institutions: Mayo Clinic, Medical University of South Carolina, University of Florida, MUSC Hollings Cancer Center, Mayo Clinic in Florida

ORCID: 0009-0000-1177-5272

Observed ORCID: 0009-0000-1177-5272

OpenAlex ID: A5114767218

A new sort of cells for chimeric antigen receptor T-cell therapies—isolating CD14–CD127+ T cells for chimeric antigen receptor T-cell manufacture

2025 · Yan Luo, Yaqing Qie, et al. · Cytotherapy · 4

Single CAR-Dual target: Intracranial Delivery of Anti-PD-L1 CAR T Cells Effectively Eradicates Glioma and Immunosuppressive Cells in the Tumor Microenvironment

2024 · Maria J. Ulloa-Navas, Yan Luo, et al. · bioRxiv (Cold Spring Harbor Laboratory) · 1

Structure and Function of Archaeal SRP54 Protein Mutants Associated with Human Severe Congenital Neutropenia

2026 · Ming Yang, Andrew D. Brim, et al. · ACS Omega

From blind to bound: CRISPR restores IL-2 responsiveness in patient Tregs

2026 · Andrew D. Brim, Leonardo M.R. Ferreira · Molecular Therapy

Novel allogeneic CAR T-cell platform involving microhomology-mediated end joining repair and low off-targeting potential

2025 · Tanya Hundal, Yan Luo, et al. · Molecular Therapy — Nucleic Acids

Abstract 4812: Intracranial delivery of MC9999 CAR T-cell therapy: a novel strategy to simultaneously eliminate GBM tumors and immunosuppressive components in the tumor microenvironment

2025 · Yan Luo, Yaqing Qie, et al. · Cancer Research

Works count: 6

Citation count: 5

H-index: 1

I10-index: